Filed under: Earnings reports, Cisco Systems (CSCO), Time Warner (TWX), Motorola (MOT), Estee Lauder (EL), NYSE Euronext (NYX), BP p.l.c. ADS (BP), Anadarko Petroleum (APC) Here are some highlights from this past week's earnings coverage from BloggingStocks: Anadarko Petroleum Corp. (NYSE: APC) repo...

Biotech, Hepatitis C, Life Sciences Luke Timmerman wrote: An early peek at data from Anadys Pharmaceuticals (NASDAQ: ANDS) suggests the company may have a promising new drug in the works for hepatitis C. The San Diego-based biotech is announcing results today from the first eight patients with the c...

"I'm an honest guy, and my first obligation is to tell the truth. Even if it means I'll probably never get to do a scientific investigation with Schering-Plough again." And: "For anyone to say the data in the study are bad, they either need to say that John Kastelein is a liar, which I'm certain he ...

As reported in today's Newark Star-Ledger, Schering-Plough's New Jersey employees will bear the brunt of Fred Hassan's plan to fire, terminate, let go with extreme prejudice, 5,500 people in S-P's workforce: "Schering-Plough's chief executive said yesterday the budget ax will fall first and hardest ...

Sometimes negative studies can provide very important insights. You have just seen a negative trial that should change practice, especially given the way that we, in this country, have been prescribing ezetimibe. There are several things to notice about this study and Dr. Kastelein’s presentation....

The pressures that Schering-Plough has been suffering amid the criticism of its cholesteriol drugs Vytorin and Zetia, sold through a joint venture with Merck & Co, has led the firm to announce major job cuts and plant closures. S-P has unveiled what it calls a “productivity transformation prog...

And we must listen! Vytorin as a drug is easy to forgive – the combination makes perfect sense, and the fact that it didn’t show a good result in ENHANCE took everyone by surprise. (And, as mentioned above, it may in the end turn out to be a good therapy in the end). But the marketing of Vytorin...

Schering-Plough CEO Fred Hassan told listeners at a recent Lehman Brothers healthcare conference that Vytorin-Zetia TV ads will soon be back on the air. This time, however, do expect to see the cute food-people comparison ads, which I thought were getting old a long time ago (see "Vytorin Ads Are Ge...

I just got this comment from an anonymous source: "Did you hear about SP's 'Zetia 49 Plan'? Apparently they gave all their reps a wad of cash to throw at doctors . . . " Thinking this was just some kind of rant, I went over to the Schering Plough company board at Cafe Pharma and discovered this inte...

I once said "God bless the dedicated researchers and scientists of the pharmaceutical industry! They are truly the unsung heroes of the pharmaceutical industry! Too bad they are sequestered in their labs!" and "If God blesses the folks in pharma R&D, the devil may take pharmaceutical marketers -...